1. Home
  2. UPLD vs ALXO Comparison

UPLD vs ALXO Comparison

Compare UPLD & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPLD
  • ALXO
  • Stock Information
  • Founded
  • UPLD 2010
  • ALXO 2015
  • Country
  • UPLD United States
  • ALXO United States
  • Employees
  • UPLD N/A
  • ALXO N/A
  • Industry
  • UPLD Computer Software: Prepackaged Software
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPLD Technology
  • ALXO Health Care
  • Exchange
  • UPLD Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • UPLD 67.6M
  • ALXO 76.5M
  • IPO Year
  • UPLD 2014
  • ALXO 2020
  • Fundamental
  • Price
  • UPLD $5.18
  • ALXO $1.99
  • Analyst Decision
  • UPLD Hold
  • ALXO Strong Buy
  • Analyst Count
  • UPLD 3
  • ALXO 5
  • Target Price
  • UPLD $3.75
  • ALXO $13.25
  • AVG Volume (30 Days)
  • UPLD 694.0K
  • ALXO 1.1M
  • Earning Date
  • UPLD 11-07-2024
  • ALXO 11-07-2024
  • Dividend Yield
  • UPLD N/A
  • ALXO N/A
  • EPS Growth
  • UPLD N/A
  • ALXO N/A
  • EPS
  • UPLD N/A
  • ALXO N/A
  • Revenue
  • UPLD $278,945,000.00
  • ALXO N/A
  • Revenue This Year
  • UPLD N/A
  • ALXO N/A
  • Revenue Next Year
  • UPLD N/A
  • ALXO N/A
  • P/E Ratio
  • UPLD N/A
  • ALXO N/A
  • Revenue Growth
  • UPLD N/A
  • ALXO N/A
  • 52 Week Low
  • UPLD $1.79
  • ALXO $1.19
  • 52 Week High
  • UPLD $5.64
  • ALXO $17.83
  • Technical
  • Relative Strength Index (RSI)
  • UPLD 65.66
  • ALXO 60.32
  • Support Level
  • UPLD $4.03
  • ALXO $1.40
  • Resistance Level
  • UPLD $5.64
  • ALXO $1.88
  • Average True Range (ATR)
  • UPLD 0.62
  • ALXO 0.19
  • MACD
  • UPLD 0.02
  • ALXO 0.02
  • Stochastic Oscillator
  • UPLD 78.60
  • ALXO 81.15

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: